Articles related to Clinical Pharmacology

Analysis of 285,680 patients shows a 1.03-1.38% reduction in cumulative mortality with rosuvastatin compared to atorvastatin, alongside varying risks for cardiovascular events, liver outcomes, and diabetes.

Risk of dementia with these medications increases proportionally with higher doses and extended duration of use, emphasizing the importance of minimal effective dosing strategies.

Recent data suggests that 57% of Americans over 20 take at least one dietary supplement, with multivitamins, vitamin D, and omega-3 fatty acids being the most popular choices.

Digoxin’s narrow therapeutic window and individual patient variability necessitate careful monitoring and consideration in clinical practice.

CGRP inhibitors have shown promise in reducing migraine days and improving quality of life, but their wide-ranging effects throughout the body warrant careful consideration and long-term monitoring.

Nearly 70% of 340B contract pharmacies are now associated with pharmacy benefit managers, potentially shifting the program’s focus away from its original intent of supporting safety-net providers.